Monitoring after rectal cancer treatment
Part of Cancer, Digestive system clinical trials.
This study looks at whether careful monitoring (watch and wait) is a good option for people with rectal cancer who have already had certain treatments. It aims to see if this approach can help avoid major surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a type of rectal cancer called adenocarcinoma (not the signet or mucinous types).
- Your cancer is locally advanced (T1-4a or N0-2) and has spread to a limited number of other places (1 to 2 organs, or 1 to 2 spots in one organ).
- Your tumor is not completely around the bowel and is less than 7 cm long.
- Your tumor is in the lower to mid rectum, up to 7 cm from the anal opening.
- You have already completed a specific set of treatments aimed at a watch and wait approach, including chemotherapy and radiation (with or without brachytherapy), by March 2024.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether some people with rectal cancer can safely avoid immediate surgery after (chemo)radiation, instead closely monitoring their response. It may help some patients reduce treatment burden if the cancer fully responds.
This trial looks at a “non-surgery” approach for some people with locally advanced rectal cancer who respond very well to radiation plus chemotherapy. If your cancer shows a complete clinical response on follow-up checks, the study may help you avoid an immediate major operation while closely monitoring you.
This study is for people with rectal cancer who have had treatment like radiation or chemo and their tumor has disappeared or nearly disappeared. Instead of surgery right away, doctors will closely monitor the cancer with regular check-ups to make sure it stays gone.
This study compares two approaches after early-stage rectal cancer is removed: either careful monitoring or a follow-up treatment with chemotherapy and radiation. The goal is to see which strategy works better to keep the cancer from returning.
This study looks at whether some people with locally advanced rectal cancer can safely delay or avoid surgery after chemoradiation by closely monitoring tumors (“watch and wait”). It may help those who strongly want to preserve the anus, but only if they meet strict safety checks.
This trial studies whether a period of active surveillance (watching closely) and chemotherapy before surgery can improve outcomes for people with stage II–III rectal cancer. You would also receive standard chemo-radiation if you qualify, then proceed to surgery.
Hear when a new Rectal Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.